Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Read the RNS guys - it’s good news but as far as I can tell it’s not the heritage agreement you’ve been waiting for
“the Company is awaiting an expenditure report from Sandfire for the option period so it can review Sandfire's Exploration Commitment which was to fund US$1 million of exploration expenditure on the Included Licences (the "Exploration Commitment") within the Option Period with 60% of the Exploration Commitment to be on drilling and assay costs. If the Exploration Commitment is not spent, any shortfall is due to be paid by Sandfire to African Pioneer.”
Have to wait and see re Sandfire. They were required to spend $600k on drilling and it sounds like they may not have. If they didn’t, they have to pay it to AFP instead, which would be a cash windfall of $600k, plus we get their exploration data and the licences back. We’ll see
I think Slacker’s point was that OBD also trades OTC on the US market, and any buys via that method would be likely to start when the US market opens. In my experience US OTC listings don’t tend to make much difference to the share prices of UK listed companies, so I wouldn’t expect too much from this aspect in particular. Then again you never know - the news is closely tied to the US
I think we have every chance to push on from here with little pullback. It’s not like when a metals explorer announces a good drill result or a biotech announces an early stage trial result and it spikes up but then the dust settles and the reality is that the company is years and a huge amount of cost away from making any money. Our news today is the actual commercial launch. Doctors will be ordering today. The testing is done, the lab validation is done, the ramp up cost is done. We’re straight into making money. And if we capture even a small percentage of the US PSA market the amount of money we’re going to be making is going to make even multiples of our present market cap look silly
Hi, former shareholder here. Somewhat baffled by this transaction. I remember that Ben has talked about the ENRG having licences adjacent to Karakubis before. Unless I’m at cross purposes here as to which ENRG licences he was talking about, what he said about them before was that ENRG were doing various work on their licences and that Kav would be keeping an eye on that to see what they could learn about the prospectivity of Karakubis. Makes sense.
Well, I don’t know whether we have learned any technical info from ENRG about their licences, but what we have learned today is that they want to sell them. More specifically they want to sell them for cash, with no retained interest. I would have thought the obvious reaction to that, based on the “watch what ENRG do” principle, would have been to take a somewhat dimmer view of Karakubis. Yet not only are Kav not doing that, they’re going the opposite way and actually buying the ENRG licences off them.
Anyone else confused?
The grades are very good. It’s a relatively short intercept but then again it’s very shallow so will certainly be commercial. It’s also only hole 1. You have to get a number of results and piece together a picture
Excellent drill results, congrats guys
Check out the new PSE pages on the OBD website. My thoughts:
https://x.com/metalhead2525/status/1703774192057942450?s=46&t=Jne_cUYLxmaxpafySDDQ2A
I can’t comment on another company’s test - I don’t know enough about it. As to whether OBD needs further tests, they say not. It is of great comfort to me that they have already launched CiRT in the US and therefore definitely know the process
Gallmat, “shareholder loan” means a loan by a shareholder to the company of which it is a shareholder, so in this case by CoTec to HyProMag US
It’s not true that “we” need to pay back the loan. The JV company, HyProMag US, will be liable on the loan. It is not clear to me from the RNS whether the JV company will have an equivalent liability to Maginito reflecting the contribution of the tech. Either way, no liability to Mkango, or indeed Maginito
Presumably if there is a small selling element it must be a member of his family rather than him, since we didn’t get a PDMR notification
It’s just the dilution effect of the fundraise, isn’t it?
Good to see directors buying more
Dr Akoulitchev hasn’t sold any - we haven’t had a PDMR notification
Hi Mr V
Reluctant to stray from fact to theory, at least on here. Happy to discuss further by Twitter DM if you like - just look me up.
Correction: I thought it was the company secretary I emailed but turns out it was director Dan Smith. Unless he used to be the company secretary - not sure
Some interesting discussion today, especially between Mr V and 12 Roses earlier on. I emailed the company secretary about the terms of the Windfield deal back in August 2022. In case of interest, I wrote, on this issue:
“Point 4 says that the Performance Payment becomes payable if “Alien disposes of its interest in the Projects”. But point 5(c) provides for how the Performance Payment will be calculated in the event a decision to mine is made. Does that mean a decision to mine made by Alien/IOCA? Presumably not, since that would not seem to involve Alien ‘disposing of its interest in the Projects”. But, if 5(c) is not referring to a decision to mine made by Alien/IOCA, what is it referring to?”
The company secretary did not reply. I chased. He did not reply. Make of that what you will. Probably nothing to be made of it
Hi easyp. Suspect your source is out of date: OBD has literally just raised a large amount of cash at 11p.
As to debt, please check the accounts but my understanding is there is no debt in the sense of borrowings. There are commercial liabilities, of course.